Endovascular rescue of long-term vascular graft implants and need for continuous surveillance

[1]  R. Biederman,et al.  Cardiovascular Magnetic Resonance Imaging—Incremental Value in a Series of 361 Patients Demonstrating Cost Savings and Clinical Benefits: An Outcome-Based Study , 2017, Clinical Medicine Insights. Cardiology.

[2]  L. Baker,et al.  Underutilization of Routine Ultrasound Surveillance after Endovascular Aortic Aneurysm Repair. , 2016, Annals of vascular surgery.

[3]  M Hassan Murad,et al.  Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. , 2015, Journal of vascular surgery.

[4]  L. Pogach,et al.  Cost of lower-limb amputation in U.S. veterans with diabetes using health services data in fiscal years 2004 and 2010. , 2014, Journal of rehabilitation research and development.

[5]  Elliot L Chaikof,et al.  The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. , 2009, Journal of vascular surgery.

[6]  M. Kahn,et al.  Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. , 2002, Journal of vascular surgery.

[7]  Willard C. Johnson,et al.  A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. , 2000, Journal of vascular surgery.

[8]  J. Mills,et al.  The failing graft: an evolving concept. , 1993, Seminars in vascular surgery.

[9]  C. McCollum,et al.  PTFE or HUV for femoro-popliteal bypass: a multi-centre trial. , 1991, European journal of vascular surgery.

[10]  Van Vroonhoven Tj,et al.  PTFE versus human umbilical vein in above knee femoro-popliteal bypass. Early results of a randomized clinical trial. , 1988 .

[11]  A. Dardik,et al.  A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. , 1988, Journal of vascular surgery.

[12]  T. van Vroonhoven,et al.  PTFE versus human umbilical vein in above knee femoro-popliteal bypass. Early results of a randomized clinical trial. , 1988, Journal of Cardiovascular Surgery.

[13]  L. Norgren,et al.  Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. , 1987, Journal of vascular surgery.

[14]  R. Baier,et al.  Biodegradation and Aneurysm Formation in Umbilical Vein Grafts: Observations and a Realistic Strategy , 1984, Annals of surgery.

[15]  C. Wolferth,et al.  Atherosclerosis and the hypoplastic aortoiliac system. , 1978, Surgery.